Latest Breaking News On - Rajeev singh raghuvanshi - Page 1 : comparemela.com

Docs support drug regulator s move to withdraw Olaparib for some cancer patients

Oncologists on Thursday supported the Drug Controller General of India's (DCGI) mandate to state authorities to withdraw AstraZeneca's anticancer generic drug Olaparib over safety concerns.Olaparib is a chemotherapy drug and is used to treat .

New delhiShyam aggarwalAbhishek shankarAstrazeneca olaparibRajeev singh raghuvanshiDr br ambedkar institute rotary cancer hospitalDepartment of radiation oncologyDrug controller generalAstrazeneca pharma indiaAssistant professorRadiation oncologyInstitute rotary cancer hospitalMedical oncologySir ganga ram hospital

Docs support drug regulator s move to withdraw Olaparib for some cancer patients | MorungExpress

Docs support drug regulator s move to withdraw Olaparib for some cancer patients | MorungExpress
morungexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morungexpress.com Daily Mail and Mail on Sunday newspapers.

New delhiRajeev singh raghuvanshiAbhishek shankarShyam aggarwalAstrazeneca olaparibDr br ambedkar institute rotary cancer hospitalDepartment of radiation oncologyDrug controller generalAstrazeneca pharma indiaAssistant professorRadiation oncologyInstitute rotary cancer hospitalMedical oncologySir ganga ram hospital

Expert Panel Asks States, UTs to Compile List of Cocktail Drugs Sold in Markets, Sets Two-Week Deadline

Expert Panel Asks States, UTs to Compile List of Cocktail Drugs Sold in Markets, Sets Two-Week Deadline
news18.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news18.com Daily Mail and Mail on Sunday newspapers.

New delhiRajeev singh raghuvanshiCentral drugs standard control organisationHealth servicesIndian council of medical researchUnion territoriesDrug technical advisory boardIndian councilMedical researchDrug controller generalSingh raghuvanshiDirectorate generalCosmetics actLok sabha electionVoter turnout

BIRAC announces launch of Regulatory Affairs & Policy Advocacy division

BIRAC announces launch of Regulatory Affairs & Policy Advocacy division
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

New delhiRajeev singh raghuvanshiAlka sharmaJitendra kumarM jagadesh kumarSonia gandhiUniversity grants commissionIndia international centreBiotechnology industry research assistance councilDepartment of scientificRegulatory affairs policy advocacyStandards authority of indiaIndustrial researchDepartment of biotechnologyCentral drugs standard control organisationCouncil of scientific industrial research

Govt doctors to provide suggestion on over-the-counter drug sale in 3 months

Over-the-counter drug sales in India are a matter of global concern as they are seen to be a leading cause of anti-microbial resistance of medicines.

Umeshd suranagiBikash medhiAnupam prakashRajeev singh raghuvanshiAbhishek agarwalKumar guptaDepartment of medicineHealth servicesInstitute of medical educationDepartment of pharmacologyVardhman mahavir medical collegeMinistry of healthIndian council of medical researchCentral drugs standard control organisationLady hardinge medical collegeDepartment of paediatrics